2020 – Page 26 – Policy & Medicine

Webinar: Understanding Proposed Changes to the ACCME Standards for Commercial Support

Court Rules FDA Exceeded Authority When It Regulated Contrast Agent As Drug

Sutter Health Settles Allegations Over Driving Up Healthcare Prices

OPDP Sends Warning Letter to Alkermes

OIG Report Questions the Use of Medicare Advantage Chart Reviews

Oncologists Rely on Pharma Reps for Information

CMS Releases 2021 Medicare Advantage and Part D Changes

AMA Says FDA Policy on Banning Some Vaping Products Doesn’t Go Far Enough

ACCME Proposes Changes to the Standards for Integrity and Independence in Accredited Continuing Education

FDA Did Not Verify Whether Opioid-Curbing Effort Worked